logo
[breadcrumb_custom]

Tag: Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)

SLGG
Industry

Merrimack Pharmaceuticals Inc (MACK) Stock: A Comprehensive 52-Week Review

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Merrimack Pharmaceuticals Inc’s current trading price is -7.49% away from its 52-week high, while its distance from the 52-week low is 30.67%. The stock’s price range during this period has varied between $11.25 and $15.89. The company, active in the Healthcare sector, saw a trading volume of around 0.24 million for the day, considerably higher average daily volume of 79100.0 observed over the last three months. The market performance of Merrimack Pharmaceuticals Inc has been

VIPS stock
News

MACK’s Market Whiplash: 11.86% YTD Rise, 13.90% Rise in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 11.86% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 22.05%. Over the past 30 days, the price of MACK has fallen by 13.90%. And in the last five days, it has surged by 13.21%. Merrimack Pharmaceuticals Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $14.21 on 02/13/24, while